BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

674 related articles for article (PubMed ID: 18853456)

  • 41. A unique intronic splicing enhancer controls the inclusion of the agrin Y exon.
    Wei N; Lin CQ; Modafferi EF; Gomes WA; Black DL
    RNA; 1997 Nov; 3(11):1275-88. PubMed ID: 9409619
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The cytochrome P450 aromatase lacking exon 5 is associated with a phenotype of nonclassic aromatase deficiency and is also present in normal human steroidogenic tissues.
    Pepe CM; Saraco NI; Baquedano MS; Guercio G; Vaiani E; Marino R; Pandey AV; Flück CE; Rivarola MA; Belgorosky A
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):698-705. PubMed ID: 17608756
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outcome of donor splice site mutations accounting for congenital afibrinogenemia reflects order of intron removal in the fibrinogen alpha gene (FGA).
    Attanasio C; David A; Neerman-Arbez M
    Blood; 2003 Mar; 101(5):1851-6. PubMed ID: 12406899
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mapping the SF2/ASF binding sites in the bovine growth hormone exonic splicing enhancer.
    Dirksen WP; Li X; Mayeda A; Krainer AR; Rottman FM
    J Biol Chem; 2000 Sep; 275(37):29170-7. PubMed ID: 10880506
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Unusual deep intronic mutations in the COL4A5 gene cause X linked Alport syndrome.
    King K; Flinter FA; Nihalani V; Green PM
    Hum Genet; 2002 Dec; 111(6):548-54. PubMed ID: 12436246
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Therapeutic modulation of DMD splicing by blocking exonic splicing enhancer sites with antisense oligonucleotides.
    Aartsma-Rus A; Janson AA; Heemskerk JA; De Winter CL; Van Ommen GJ; Van Deutekom JC
    Ann N Y Acad Sci; 2006 Oct; 1082():74-6. PubMed ID: 17145928
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Disruption of exonic splicing enhancer elements is the principal cause of exon skipping associated with seven nonsense or missense alleles of NF1.
    Zatkova A; Messiaen L; Vandenbroucke I; Wieser R; Fonatsch C; Krainer AR; Wimmer K
    Hum Mutat; 2004 Dec; 24(6):491-501. PubMed ID: 15523642
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structural determinants for alternative splicing regulation of the MAPT pre-mRNA.
    Lisowiec J; Magner D; Kierzek E; Lenartowicz E; Kierzek R
    RNA Biol; 2015; 12(3):330-42. PubMed ID: 25826665
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic interactions between the 5' and 3' splice site consensus sequences and U6 snRNA during the second catalytic step of pre-mRNA splicing.
    Collins CA; Guthrie C
    RNA; 2001 Dec; 7(12):1845-54. PubMed ID: 11780639
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular diagnosis of Stickler syndrome: a COL2A1 stop codon mutation screening strategy that is not compromised by mutant mRNA instability.
    Freddi S; Savarirayan R; Bateman JF
    Am J Med Genet; 2000 Feb; 90(5):398-406. PubMed ID: 10706362
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antisense modulation of both exonic and intronic splicing motifs induces skipping of a DMD pseudo-exon responsible for x-linked dilated cardiomyopathy.
    Rimessi P; Fabris M; Bovolenta M; Bassi E; Falzarano S; Gualandi F; Rapezzi C; Coccolo F; Perrone D; Medici A; Ferlini A
    Hum Gene Ther; 2010 Sep; 21(9):1137-46. PubMed ID: 20486769
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A point mutation in the lariat branch point of intron 6 of NPC1 as the cause of abnormal pre-mRNA splicing in Niemann-Pick type C disease.
    Di Leo E; Panico F; Tarugi P; Battisti C; Federico A; Calandra S
    Hum Mutat; 2004 Nov; 24(5):440. PubMed ID: 15459971
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of exonic mutations leading to exon skipping in patients with pyruvate dehydrogenase E1 alpha deficiency.
    Cardozo AK; De Meirleir L; Liebaers I; Lissens W
    Pediatr Res; 2000 Dec; 48(6):748-53. PubMed ID: 11102541
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intronic mutation in the PGK1 gene may cause recurrent myoglobinuria by aberrant splicing.
    Shirakawa K; Takahashi Y; Miyajima H
    Neurology; 2006 Mar; 66(6):925-7. PubMed ID: 16567715
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A deep intronic mutation in the RB1 gene leads to intronic sequence exonisation.
    Dehainault C; Michaux D; Pagès-Berhouet S; Caux-Moncoutier V; Doz F; Desjardins L; Couturier J; Parent P; Stoppa-Lyonnet D; Gauthier-Villars M; Houdayer C
    Eur J Hum Genet; 2007 Apr; 15(4):473-7. PubMed ID: 17299438
    [TBL] [Abstract][Full Text] [Related]  

  • 56. SR proteins and hnRNP H regulate the splicing of the HIV-1 tev-specific exon 6D.
    Caputi M; Zahler AM
    EMBO J; 2002 Feb; 21(4):845-55. PubMed ID: 11847131
    [TBL] [Abstract][Full Text] [Related]  

  • 57. NSSRs/TASRs/SRp38s function as splicing modulators via binding to pre-mRNAs.
    Fushimi K; Osumi N; Tsukahara T
    Genes Cells; 2005 Jun; 10(6):531-41. PubMed ID: 15938712
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An LKB1 AT-AC intron mutation causes Peutz-Jeghers syndrome via splicing at noncanonical cryptic splice sites.
    Hastings ML; Resta N; Traum D; Stella A; Guanti G; Krainer AR
    Nat Struct Mol Biol; 2005 Jan; 12(1):54-9. PubMed ID: 15608654
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Novel Mutation in the Fibrinogen Bβ Chain (c.490G>A; End of Exon 3) Causes a Splicing Abnormality and Ultimately Leads to Congenital Hypofibrinogenemia.
    Taira C; Matsuda K; Arai S; Sugano M; Uehara T; Okumura N
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29156616
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Correction of aberrant FGFR1 alternative RNA splicing through targeting of intronic regulatory elements.
    Bruno IG; Jin W; Cote GJ
    Hum Mol Genet; 2004 Oct; 13(20):2409-20. PubMed ID: 15333583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.